Literature DB >> 9414767

Donor-transmitted IgA nephropathy: long-term follow-up of kidney donors and recipients.

M Koselj1, T Rott, A Kandus, A Vizjak, M Malovrh.   

Abstract

Entities:  

Mesh:

Year:  1997        PMID: 9414767     DOI: 10.1016/s0041-1345(97)00957-3

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Allogeneic bone marrow transplantation appears to ameliorate IgA nephropathy in a patient with X-linked thrombocytopenia.

Authors:  Akihiro Hoshino; Masaki Shimizu; Hiroyoshi Matsukura; Hisano Sakaki-Nakatsubo; Keiko Nomura; Toshio Miyawaki; Hirokazu Kanegane
Journal:  J Clin Immunol       Date:  2013-11-12       Impact factor: 8.317

2.  Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.

Authors:  Y Wang; M-H Zhao; Y-K Zhang; X-M Li; H-Y Wang
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

Review 3.  Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathy.

Authors:  Mototsugu Tanaka; George Seki; Tomonosuke Someya; Michio Nagata; Toshiro Fujita
Journal:  Clin Dev Immunol       Date:  2011-01-24

4.  IgA nephropathy in identical twins: an excellent donor and recipient outcome 11 years after transplantation.

Authors:  John Irvine; Nicholas Cross; Kelvin Lynn; Richard Robson; Martin Searle; John Morton; Sarah Armstrong; Justin Roake
Journal:  Clin Kidney J       Date:  2012-03-26

5.  Race/ethnicity and disease severity in IgA nephropathy.

Authors:  Yoshio N Hall; Eloisa F Fuentes; Glenn M Chertow; Jean L Olson
Journal:  BMC Nephrol       Date:  2004-09-02       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.